Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study - PubMed
3 hours ago
- #Atrial Fibrillation
- #Mavacamten
- #Hypertrophic Cardiomyopathy
- Study focuses on incidence and outcomes of atrial fibrillation and systolic dysfunction in patients with obstructive hypertrophic cardiomyopathy treated with Mavacamten.
- Multicenter study design ensures diverse patient data and robust findings.
- Published in a reputable journal with DOI: 10.1016/j.cardfail.2026.02.035 and PMID: 41775292.